Recent Updates
Recently added Catalysts

Biotech M&A Tracker

Track biopharma mergers, acquisitions, and predicted takeover targets with deal premiums and therapeutic area analysis.
$942BIndustry FirepowerEY 2026
$136B → $370BGrowth Gap by 2028 (2032)EY Firepower
20Deals YTD
31%Avg Premium
$240B2025 M&A Value

This Week's Movers

last 7 days
  • KROS33 -24 pts
    Financial Vulnerability
  • CELC58 7 pts
    Acquirer Demand
  • DFTX31 -6 pts
    SEC Filings
  • ATAI25 -5 pts
    Fundamental Valuation
  • MMM20 5 pts
    Pipeline Attractiveness

Acquirer Urgency Heatmap

click to drill down
  • MRKMerck10/10
  • BMYBristol-Myers Squibb10/10
  • PFEPfizer8/10
  • BIIBBiogen6/10
  • AMGNAmgen7/10
  • GILDGilead Sciences7/10
  • AZNAstraZeneca6/10
  • NVSNovartis6/10

Recent Deals

latest 5
  • Jun 9Pending
    Nuvalent, Inc.GSK plc
    $10.6B+40% premoncology
    Predicted by BiopharmaWatch
  • May 20Announced
    Engage BiologicsEli Lilly and Company
    $202Mdrug delivery
  • May 6Announced
    PathAI, Inc.Roche Holding AG
    $1.5Bdiagnostics
  • Apr 27Announced
    Ajax Therapeutics, Inc.Eli Lilly and Company
    $2.3Boncology
  • Apr 7Pending
    Tubulis GmbHGilead Sciences, Inc.
    $5.0Boncology

Top 10 Targets - Probability Leaderboard

#TickerCompanyScoreTierTop Acquirer MatchLead Asset
1VSTM72HIGHGILDABBVPFE
2PVLA70HIGHBIIBGILDABBV
3XFOR70HIGHBMYBIIBJNJ
4NUVB69HIGHREGNAZNMRK
5SNDX67HIGHAZNMRKBMY